Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex testing service for cloud gaming

4/11/24 YNDX

Softline completed an additional exchange of Noventiq receipts

4/11/24 SOFL

CEO of ICPAO Yandex Artem Savinovsky appointed

4/11/24 YNDX

Gazprom Neft migrated to Astra Linux for 85% employees

4/11/24 ASTR

Board of Directors of Rosbank recommended dividends

4/10/24 ROSB

Southern Kuzbass reported for 2023 by IFRS

4/10/24 UKUZ

SberUnity launched syndicated transactions

4/10/24 SBER

Board of Directors of NLMK recommended dividends

4/10/24 NLMK

SberUnity launched syndicated transactions

4/10/24 OTCI

Korshunovsky GOK reported for 2023 by IFRS

4/10/24 KOGK